国际肿瘤学杂志 ›› 2026, Vol. 53 ›› Issue (11): 664-670.doi: 10.3760/cma.j.cn371439-20260318-00104

• 论著 • 上一篇    下一篇

Claudin18.2抗体不同克隆号在胃腺癌组织中的表达一致性分析

袁丽娟1, 冯莎1, 陈爱文1, 关剑1,2, 罗娜1, 叶晓星1, 张绪文1, 黄文亭1,2()   

  1. 1 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院深圳医院病理科, 深圳 518116
    2 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院病理科, 北京 100021
  • 收稿日期:2026-03-18 出版日期:2026-11-08 发布日期:2026-11-05
  • 通讯作者: 黄文亭,Email: huangwt@cicams.ac.cn
  • 作者简介:

    袁丽娟:数据收集、整理,实验操作,论文撰写与修改;冯莎:数据整理、实验结果判读、论文修改;陈爱文:数据整理、统计学分析、论文撰写与修改;关剑:实验结果判读、论文修改;罗娜、叶晓星、张绪文:论文修改;黄文亭:研究指导、实验结果判读、论文撰写与修改

  • 基金资助:
    深圳市“医疗卫生三名工程”项目(SZSM202411001)

Concordance analysis of Claudin18.2 expression with different antibody clone numbers in gastric adenocarcinoma tissues

Yuan Lijuan1, Feng Sha1, Chen Aiwen1, Guan Jian1,2, Luo Na1, Ye Xiaoxing1, Zhang Xuwen1, Huang Wenting1,2()   

  1. 1 Department of Pathology, National Cancer Center/National Cancer Clinical Research Center/Cancer Hospital of Chinese Academy of Medical Sciences, Peking Union Medical College, Shenzhen Branch, Shenzhen 518116, China
    2 Department of Pathology, National Cancer Center/National Cancer Clinical Research Center/Cancer Hospital of Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China
  • Received:2026-03-18 Online:2026-11-08 Published:2026-11-05
  • Supported by:
    "Sanming Project of Medicine" in Shenzhen(SZSM202411001)

摘要:

目的 分析Claudin18.2抗体不同克隆号在胃腺癌组织中的表达一致性。 方法 选取2023年12月—2024年9月中国医学科学院北京协和医学院肿瘤医院深圳医院经Claudin18.2抗体克隆号EPR19202检测的56例胃腺癌(包括食管胃交界腺癌)初诊患者作为研究对象,所有患者再进行克隆号43-14A检测,比较两种不同克隆号抗体的阳性检出率差异;通过组内相关系数(ICC)及Cohen's Kappa系数评估两种抗体染色后不同强度阳性细胞比例判读结果的一致性;采用Spearman相关系数评估两种抗体表达水平的相关性。 结果 EPR19202、43-14A两种克隆号Claudin18.2抗体检测结果显示,阳性染色均定位于正常胃黏膜上皮细胞及肿瘤细胞的细胞膜,EPR19202显色呈棕色至棕黄色,而43-14A显色呈棕褐色至深褐色。EPR19202阳性病例13例,阴性43例,阳性率为23.21%;43-14A阳性病例24例,阴性32例,阳性率42.86%,43-14A阳性率显著高于EPR19202,差异具有统计学意义(χ2=4.04,P=0.045)。ICC评估结果显示,在EPR19202染色切片中,3位医师对该克隆号抗体染色切片中、强阳性细胞百分比判读的ICC值分别为0.87、0.78;在43-14A染色切片中对应的ICC值分别为0.80、0.91。3位医师对两抗体染色切片阴阳性判读完全一致率为84%~93%,Cohen's Kappa值为0.56~0.86,根据Landis & Koch标准,3位医师的判读一致性达中等至几乎完全一致水平,且43-14A判读一致性更优。Spearman相关性分析结果显示,两种克隆号在中阳性细胞比例上呈中度至高度正相关(r=0.49,P<0.001;r=0.60,P<0.001;r=0.65,P<0.001),而在强阳性细胞比例上呈中度正相关(r=0.41,P=0.002;r=0.51,P<0.001;r=0.49,P=0.001),提示两者表达水平存在中等程度相关性;3位医师共同判读的Cohen's Kappa值为0.57。 结论 Claudin18.2抗体EPR19202与43-14A两种克隆号阳性染色定位准确,可用于胃腺癌及相关癌前病变的Claudin18.2检测。两种克隆号检测结果具有中等及以上的相关性,但在弱阳性、高异质性病例中存在一定差异,43-14A克隆号在胃腺癌组织中阳性检出率更高,病理医师判读的一致性更优。

关键词: 胃肿瘤, 紧密连接蛋白质类, 抗体, 单克隆, 免疫组织化学, 一致性分析

Abstract:

Objective To analyze the concordance of Claudin18.2 expression with different antibody clone numbers in gastric adenocarcinoma tissues. Methods A total of 56 newly diagnosed cases of gastric adenocarcinoma (including oesophagogastric junction adenocarcinoma) who were tested using Claudin18.2 clone number EPR19202 at Cancer Hospital of Chinese Academy of Medical Sciences, Peking Union Medical College, Shenzhen Branch from December 2023 to September 2024 were selected as the research subjects. All patients were then tested with clone number 43-14A, and the positive detection rates of the two different clone number antibodies were compared. The intraclass correlation coefficient (ICC) and Cohen's Kappa coefficient were adopted to evaluate the consistency of the interpretation results of positive cell proportions with different intensities after staining with the two antibodies. Additionally, the Spearman correlation coefficient was employed to assess the correlation of expression levels detected by the two antibodies. Results The positive staining of Claudin18.2 detected by both antibodies EPR19202 and 43-14A was exhibited membranous staining in normal gastric mucosal epithelial cells and tumor cells. EPR19202 demonstrated brown to yellow-brown staining, while 43-14A showed brown to dark brown staining. Regarding the positive detection rate, there were 13 positive cases and 43 negative cases for EPR19202, resulting in a positive rate of 23.21%. For 43-14A, there were 24 positive cases and 32 negative cases, yielding a positive rate of 42.86%. The positive rate of 43-14A was significantly higher than that of EPR19202, indicating a statistically significant difference between the two positive rates (χ2=4.04, P=0.045). The ICC assessment results showed that in the EPR19202 stained sections, the ICC values for the three physicians' interpretation of the percentages of moderately and strongly positive cells in this clone antibody stained sections were 0.87 and 0.78 respectively; in the 43-14A stained sections, the corresponding ICC values were 0.80 and 0.91, respectively. The complete consistency rate of the three physicians' interpretation of the positive/negative judgment of the two antibody stained sections was 84% to 93%, with a Cohen's Kappa value ranging from 0.56 to 0.86. According to the Landis & Koch standard, the consistency of the three physicians' interpretation reached a moderate to almost complete consistent level, and the consistency of 43-14A interpretation was better. The Spearman correlation analysis results showed that the two clone numbers were moderately to highly positively correlated in the proportion of moderately positive cells (r=0.49, P<0.001; r=0.60, P<0.001; r=0.65, P<0.001), and moderately positively correlated in the proportion of strongly positive cells (r=0.41, P=0.002; r=0.51, P<0.001; r=0.49, P=0.001), suggesting that there was a moderate correlation in their expression levels; the Cohen's Kappa value of the three physicians' joint interpretation was 0.57. Conclusions Both Claudin18.2 antibodies, EPR19202 and 43-14A, show accurate positive staining localization, making them suitable for detecting Claudin18.2 in gastric adenocarcinoma and related precancerous lesions. The two clones show moderate to high correlation in detection results, but certain discrepancies are observed in weakly positive and highly heterogeneous cases. Clone 43-14A demonstrates a higher positivity rate in gastric adenocarcinoma tissues and better consistency in physicians' interpretation.

Key words: Stomach neoplasms, Tight junction proteins, Antibodies, monoclonal, Immunohistoche-mistry, Consistency analysis